T3	Treatment 35 54	adalimumab (160 mg)
T5	Effect 149 173	fulminant cardiomyopathy
T8	Sub-Disorder 108 123	Crohn's disease
T9	Drug 35 45	adalimumab
T10	Dosage 47 53	160 mg
T6	Subject 83 136	an acute exacerbation of Crohn's disease, the patient
